Tumor Necrosis Factor inhibition in treating sarcoidosis: the American Experience
Biological agents which specifically block tumor necrosis factor (TNF) have been reported as useful in treating sarcoidsis. Over the past four years, many centers in America have reported on the use of one or more anti-TNF agent. These are: the TNF receptor antagonist etanerecept, the chimeric monoc...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2007-10-01
|
| Series: | Revista Portuguesa de Pneumologia |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0873215915304037 |